Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fidaxomicin”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Post-approval studies (Phase 4)Ended earlyNCT01775397
What this trial is testing

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe Ltd. 12
Large-scale testing (Phase 3)Study completedNCT05201079
What this trial is testing

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Who this might be right for
Recurrent Clostridium Difficile InfectionPrimary Clostridium Difficile Infection
Mikrobiomik Healthcare Company S.L. 93
Not applicableStudy completedNCT02461901
What this trial is testing

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Who this might be right for
Clostridium Difficile Infection
Professor Mark Wilcox 203
Post-approval studies (Phase 4)Not Yet RecruitingNCT06794944
What this trial is testing

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection
Brigham and Women's Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT05266807
What this trial is testing

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

Who this might be right for
Clostridioides Difficile Infection
Benoit Guery 220
Early research (Phase 1)Study completedNCT02083627
What this trial is testing

Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male Subjects

Who this might be right for
Drug-Drug Interaction (DDI)Intestinal AbsorptionHealthy Subjects+2 more
Astellas Pharma Europe B.V. 25
Not applicableNot Yet RecruitingNCT07120490
What this trial is testing

STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceFecal Microbiota Transplantation (FMT)+3 more
Medical University of Warsaw 424
Early research (Phase 1)Study completedNCT01813448
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

Who this might be right for
Pharmacokinetics of FidaxomicinHealthy Subjects
Astellas Pharma Global Development, Inc. 36
Not applicableEnded earlyNCT01533844
What this trial is testing

To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the Pathogenesis

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe B.V. 1
Not applicableStudy completedNCT02214771
What this trial is testing

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Who this might be right for
Clostridium Difficile Infection
Astellas Pharma S.A.S. 296
Post-approval studies (Phase 4)Study completedNCT02437591
What this trial is testing

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridium Difficile Infection (CDI)
Astellas Pharma Europe Ltd. 25
Testing effectiveness (Phase 2)Ended earlyNCT03760484
What this trial is testing

Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile
University of Alberta 4
Large-scale testing (Phase 3)Study completedNCT00468728
What this trial is testing

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 535
Post-approval studies (Phase 4)Study completedNCT02692651
What this trial is testing

A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent Infections

Who this might be right for
Clostridium Difficile Infection (CDI)
University of Michigan 144
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Post-approval studies (Phase 4)WithdrawnNCT02464306
What this trial is testing

Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionSolid Organ Transplant
University of Colorado, Denver
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Testing effectiveness (Phase 2)Study completedNCT02784002
What this trial is testing

Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
Summit Therapeutics 27
Load More Results